| 000 | 01834 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515063319.0 | ||
| 264 | 0 | _c20070529 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1049-2275 | ||
| 024 | 7 |
_a10.1097/scs.0b013e3180336047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMooney, Mark P | |
| 245 | 0 | 0 |
_aPostoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. _h[electronic resource] |
| 260 |
_bThe Journal of craniofacial surgery _cMar 2007 |
||
| 300 |
_a336-46; discussion 347-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain _xgrowth & development |
| 650 | 0 | 4 | _aCephalometry |
| 650 | 0 | 4 |
_aCraniosynostoses _xetiology |
| 650 | 0 | 4 |
_aCraniotomy _xadverse effects |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aPostoperative Care |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 |
_aSkull _xgrowth & development |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta2 _xantagonists & inhibitors |
| 700 | 1 | _aLosken, H Wolfgang | |
| 700 | 1 | _aMoursi, Amr M | |
| 700 | 1 | _aShand, Jocelyn M | |
| 700 | 1 | _aCooper, Gregory M | |
| 700 | 1 | _aCurry, Chris | |
| 700 | 1 | _aHo, Lillian | |
| 700 | 1 | _aBurrows, Anne M | |
| 700 | 1 | _aStelnicki, Eric J | |
| 700 | 1 | _aLosee, Joseph E | |
| 700 | 1 | _aOpperman, Lynne A | |
| 700 | 1 | _aSiegel, Michael I | |
| 773 | 0 |
_tThe Journal of craniofacial surgery _gvol. 18 _gno. 2 _gp. 336-46; discussion 347-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/scs.0b013e3180336047 _zAvailable from publisher's website |
| 999 |
_c16966049 _d16966049 |
||